Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
February 7, 2024 — Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover ...
February 7, 2024 — Researchers presenting preliminary late-breaking science presented on the first day of the American ...
February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...
February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...
February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...
February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
February 1, 2024 —  Genomics plc (Genomics), a healthcare company aiming to transform health through the power of ...
January 31, 2024 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) appro ...
January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at ...
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...
January 23, 2024 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...
January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular ...
January 19, 2024 — Orchestra BioMed, a biomedical company accelerating high-impact technologies to patients through risk ...
January 19, 2024 — W. L. Gore & Associates, Inc. announced that the first patients have been enrolled in the Gore VBX FO ...